Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

Clinical trial NCT06458413 · UNKNOWN

Trial details

NCT number: NCT06458413
Sponsor: Min Yan, MD
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Recurrent

Start date: 2024-06-05
Primary completion: 2025-06-05
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.